“Dose Reduction of Ibrutinib in Chronic Lymphocytic Leukemia: Long-Term Outcomes from a Real-World Single-Center Experience”. Mediterranean Journal of Hematology and Infectious Diseases 18, no. 1 (October 31, 2026): e2026090. Accessed November 1, 2026. https://www.mjhid.org/mjhid/article/view/6535.